Перегляд вихідного коду сторінки Tyro3 Protein Tyrosine Kinase

d management. Circulation 109: 31223131. 10.1161/01.CIR.0000133187.74800.B9;109/ 25/3122. five. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ A systematic overview of your diagnostic accuracy of [http://www.medchemexpress.com/Ruxolitinib-phosphate.html MedChemExpress INCB018424 phosphate] natriuretic peptides for heart failure. Arch Intern Med 164: 19781984. 164/18/1978;ten.1001/archinte.164.18.1978. six. Feola M, Garrone O, Occelli M, Francini A, Biggi A, et al. Cardiotoxicity following anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. Int J Cardiol 148: 194198. S0167-527301575-7;ten.1016/j.ijcard.2009.09.564. 7. Pichon MF, Cvitkovic F, Hacene K, Delaunay J, Lokiec F, et al. Druginduced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays  and radionuclide ventriculography. In Vivo 19: 567576. eight. Vogelsang TW, Jensen RJ, Hesse B, Kjaer A BNP can not replace gated equilibrium radionuclide ventriculography in monitoring of anthracyclineinduced cardiotoxity. Int J Cardiol 124: 193197. S0167-527300472-X;10.1016/j.ijcard.2007.02.003. 9. Daugaard G, Lassen U, Bie P, Pedersen EB, Jensen KT, et al. Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ten. ejection fraction. Eur J Heart Fail 7: 8793. S1388984204001059;10.1016/ j.ejheart.2004.03.009. Meinardi MT, van Veldhuisen DJ, Gietema JA, Dolsma WV, Boomsma F, et al. Prospective evaluation of early cardiac damage induced by epirubicincontaining adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol 19: 27462753. Nousiainen T, Jantunen E, Vanninen E, Remes J, Vuolteenaho O, et al. Natriuretic peptides as markers of cardiotoxicity in the course of doxorubicin remedy for non-Hodgkin's lymphoma. Eur J Haematol 62: 135141. Nousiainen T, Vanninen E, Jantunen E, Puustinen J, Remes J, et al. Natriuretic peptides during the improvement of doxorubicin-induced left ventricular diastolic dysfunction. J Intern [http://www.ncbi.nlm.nih.gov/pubmed/16574785 16574785] Med 251: 228234. 951. Okumura H, Iuchi K, Yoshida T, Nakamura S, Takeshima M, et al. Brain natriuretic peptide is really a predictor of anthracycline-induced cardiotoxicity. Acta Haematol 104: 158163. 46508;46508. Garrone O, Crosetto N, Lo NC, Catzeddu T, Vivenza D, et al. Prediction of Anthracycline Cardiotoxicity right after Chemotherapy by Biomarkers Kinetic Evaluation. Cardiovasc Toxicol. ten.1007/s12012-011-9149-4. Dolci A, Dominici R, Cardinale D, Sandri MT, Panteghini M Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic evaluation in the literature and recommendations for use. Am J Clin Pathol 130: 688695. B72890MQ9X2W15P5;10.1309/AJCPB66LRIIVMQDR. Lee HS, Son CB, Shin SH, Kim YS Clinical correlation among brain natriutetic peptide and anthracyclin-induced cardiac toxicity. Cancer Res Treat 40: 121126. ten.4143/crt.2008.40.3.121. Lynge E, Sandegaard JL, Rebolj M The Danish National Patient Register. Scand J Public Health 39: 3033. 39/7_suppl/30;10.1177/ 1403494811401482. 11. 12. 13. 14. 15. 16. 17. 9 BNP and Chemotherapy-Related Cardiac Failure 18. Helweg-Larsen K The Danish Register of Causes of Death. Scand J Public Well being 39: 2629. 39/7_suppl/26;10.1177/1403494811399958. 19. Gutte H, Mortensen J, Jensen CV, von der Recke P, Petersen CL, et al. ANP, BNP and D-dimer predict proper ventricular dysfunction in sufferers with acute pulmonary embolism. Clin Physiol Funct Imaging 30: 466472. CPF967;ten.1111/j.1475-097X.2010.00967.x.